Comparison of graft patency, limb salvage, and antithrombotic therapy between prosthetic and autogenous below-knee bypass for critical limb ischemia

Annals of Vascular Surgery

Volumn 27, Issue 8, 2013, Pages 1134-1145

  Suckow, Bjoern D ^a   Kraiss, Larry W ^a   Stone, David H ^b   Schanzer, Andres ^c   Bertges, Daniel J ^d   Baril, Donald T ^c   Cronenwett, Jack L ^b   Goodney, Philip P ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; BELOW KNEE BYPASS; BLEEDING; BLOOD TRANSFUSION; COMPARATIVE STUDY; CONFERENCE PAPER; CRITICAL LIMB ISCHEMIA; FEMALE; GRAFT PATENCY; HUMAN; INCIDENCE; LIMB AMPUTATION; LIMB SALVAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPLITEAL ARTERY; PRIORITY JOURNAL; PROPENSITY SCORE; REOPERATION; SAPHENOUS VEIN GRAFT; UNITED STATES; VASCULAR SURGERY; VEIN ANASTOMOSIS;

ADULT; AGED; AGED, 80 AND OVER; BLOOD TRANSFUSION; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CRITICAL ILLNESS; FEMALE; FIBRINOLYTIC AGENTS; GRAFT OCCLUSION, VASCULAR; HUMANS; ISCHEMIA; KAPLAN-MEIER ESTIMATE; LEG; LIMB SALVAGE; MALE; MIDDLE AGED; NEW ENGLAND; PATIENT SELECTION; PERIPHERAL ARTERIAL DISEASE; POLYTETRAFLUOROETHYLENE; POSTOPERATIVE HEMORRHAGE; PROPENSITY SCORE; PROSTHESIS DESIGN; REGISTRIES; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS; SAPHENOUS VEIN; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 84885986485     PISSN: 08905096     EISSN: 16155947     Source Type: Journal    
DOI: 10.1016/j.avsg.2013.01.019     Document Type: Conference Paper

References (34)

1. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic). Circulation 2006;113:-463-5.
2. Archie JP Jr. Femoropopliteal bypass with either adequate ipsilateral reversed saphenous vein or obligatory polytetrafluoroethylene. Ann Vasc Surg 1994;8:475-84.
3. Nicoloff AD, Taylor LM Jr, McLafferty RB, Moneta GL, Porter JM. Patient recovery after infrainguinal bypass grafting for limb salvage. J Vasc Surg 1998;27:256-63.
4. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007;33(Suppl. 1)):S1-75.
5. Green RM, Abbott WM, Matsumoto T, et al. Prosthetic above-knee femoropopliteal bypass grafting: five-year results of a randomized trial. J Vasc Surg 2000;31:417-25.
6. AbuRahma AF, Robinson PA, Holt SM. Prospective controlled study of polytetrafluoroethylene versus saphenous vein in claudicant patients with bilateral above knee femoropopliteal bypasses. Surgery 1999;126:594-601.
7. Klinkert P, Post PN, BreslauPJ,vanBockelJH. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. a review of the literature. Eur J Vasc Endovasc Surg 2004;27:357-62.
8. Hunink MG, Wong JB, Donaldson MC, Meyerovitz MF, Harrington DP. Patency results of percutaneous and surgical revascularization for femoropopliteal arterial disease. Med Decis Making 1994;14:71-81.
9. Schweiger H, Klein P, Lang W. Tibial bypass grafting for limb salvage with ringed polytetrafluoroethylene prostheses: results of primary and secondary procedures. J Vasc Surg 1993;18:867-74.
10. Albers M, Battistella VM, Romiti M, Rodrigues AA, Pereira CA. Meta-analysis of polytetrafluoroethylene bypass grafts to infrapopliteal arteries. J Vasc Surg 2003;37:1263-9.
11. Collaborative overview of randomised trials of antiplatelet therapydII: Maintenance of vascular graft or arterial patency by antiplatelet therapy. BMJ 1994;308:159-68.
12. Dorffler-Melly J, Buller HR, Koopman MM, Prins MH. Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery. Cochrane Database Syst Rev 2003;CD000536.
13. Belch JJ, Dormandy J, Biasi GM, et al. Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. J Vasc Surg 2010;52:825-33.
14. Sarac TP, Huber TS, Back MR, et al. Warfarin improves the outcome of infrainguinal vein bypass grafting at high risk for failure. J Vasc Surg 1998;28:446-57.
15. Brumberg RS, Back MR, Armstrong PA, et al. The relative importance of graft surveillance and warfarin therapy in infrainguinal prosthetic bypass failure. J Vasc Surg 2007;46:1160-6.
16. Cronenwett JL, Likosky DS, Russell MT, Eldrup- Jorgensen J, Stanley AC, Nolan BW. A regional registry for quality assurance and improvement: the Vascular Study Group of Northern New England (VSGNNE). J Vasc Surg 2007;46:1093-101.
17. Marubini E, Braga M, Leite ML, Petroccione A, Pirotta N. "Within patient"-dependent outcomes in graft occlusion after coronary artery bypass. SINBA Group. Control Clin Trials 1993;14:296-307.
18. Rosenbaum P, Rubin D. The central role of the propensity score in observational studies for causal effects. Biometrika 1983;70:41-55.
19. Becker S, Ichino A. Estimation of average treatment effects based on propensity scores. Stata J 2002;2:358-77.
20. Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997;26:517-38.
21. Kunlin J. [Le traitement de l'arterite obliterante par la greffe veineuse.] Arch Mal Coeur 1949;43:371.
22. Faries PL, Logerfo FW, Arora S, et al. A comparative study of alternative conduits for lower extremity revascularization: all-autogenous conduit versus prosthetic grafts. J Vasc Surg 2000;32:1080-90.
23. Taylor LM Jr, Edwards JM, Porter JM. Present status of reversed vein bypass grafting: five-year results of a modern series. J Vasc Surg 1990;11:193-205.
24. Belkin M, Conte MS, Donaldson MC, Mannick JA, Whittemore AD. Preferred strategies for secondary infrainguinal bypass: lessons learned from 300 consecutive reoperations. J Vasc Surg 1995;21:282-93.
25. Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomised trial. Lancet 2000;355:346-51.
26. Kashyap VS, Ahn SS, Quinones-Baldrich WJ, et al. Infrapopliteal- lower extremity revascularization with prosthetic conduit: a 20-year experience. Vasc Endovasc Surg 2002;36:255-62.
27. Moawad J, Gagne P. Adjuncts to improve patency of infrainguinal prosthetic bypass grafts. Vasc Endovasc Surg 2003;37: 381-6.
28. Oderich GS, Panneton JM, Yagubyan M, et al. Comparison of precuffed and vein-cuffed expanded polytetrafluoroethylene grafts for infragenicular arterial reconstructions: a casematched study. Ann Vasc Surg 2005;19:49-55.
29. Kreienberg PB, Darling RC 3rd, Chang BB, et al. Early results of a prospective randomized trial of spliced vein versus polytetrafluoroethylene graft with a distal vein cuff for limb-threatening ischemia. J Vasc Surg 2002;35: 299-306.
30. Pappas PJ, Hobson RW 2nd, Meyers MG, et al. Patency of infrainguinal polytetrafluoroethylene bypass grafts with distal interposition vein cuffs. Cardiovasc Surg 1998;6: 19-26.
31. Arvela E, Soderstrom M, Alback A, Aho PS, Venermo M, Lepantalo M. Arm vein conduit vs prosthetic graft in infrainguinal revascularization for critical leg ischemia. J Vasc Surg 2010;52:616-23.
32. Hughes K, Domenig CM, Hamdan AD, et al. Bypass to plantar and tarsal arteries: an acceptable approach to limb salvage. J Vasc Surg 2004;40:1149-57.
33. Alexander J, Gutierrez C, Katz S. Non-greater saphenous vein grafting for infrageniculate bypass. Am Surg 2002;68: 611-4.
34. Rowe VL, Kumar SR, Glass H, Hood DB, Weaver FA. Race independently impacts outcome of infrapopliteal bypass for symptomatic arterial insufficiency. Vasc Endovasc Surg 2007;41:397-401.